Dasatinib-related bleeding "mild and manageable"

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1259, 2009-01, pp. : 5-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anastrozole-related bone loss "manageable"

By  

Reactions Weekly, Vol. 1, Iss. 1326, 2010-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Risk of Bleeding Related to Antithrombotic Treatment in Cardiovascular Disease

By  

Current Pharmaceutical Design, Vol. 18, Iss. 33, 2012-11 ,pp. : 5362-5378

Bentham Science Publishers

Access to resources Recommend Favorite

Patient education could reduce warfarin-related bleeding costs

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 611, 2010-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Bleeding risk and safety profile related to the use of eptifibatide: a current review

By Saab Fadi   Ionescu Costin   J. Schweiger Marc  

Expert Opinion on Drug Safety, Vol. 11, Iss. 2, 2012-03 ,pp. : 315-324

Informa Healthcare

Access to resources Recommend Favorite

Dasatinib: BMS 354825

By Adis International Limited  

Drugs in R&D, Vol. 7, Iss. 2, 2006-01 ,pp. : 129-132

Adis International

Access to resources Recommend Favorite